Review summary
Historical dates
February 15, 1820 – March 13, 1906Synthetic DOB
1820-02-15Index visit
1905-03-16 at age 85Synthetic MRN
HR-NI014-SYN-TDTeaching objective: Diagnose heart failure with preserved ejection fraction in an active woman of 85 and manage it with decongestion, an SGLT2 inhibitor, blood pressure control, daily weights, and laboratory and KCCQ monitoring on the CMID schedule, while protecting her independence and travel and keeping pneumonia prevention in view.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| February 15, 1820 | Born in Adams, Massachusetts. | CLM-0001 |
| November 25, 1862 | Father died after a two-week illness. | CLM-0003 |
| November 1872 | Voted in the presidential election and was arrested. | CLM-0002 |
| January 1891 | Collapsed with la grippe in Brookline; pneumonia threatened. | CLM-0005 |
| July 26, 1895 | Fainted while speaking at Lakeside, Ohio; a month in bed afterward. | CLM-0006 |
| 1898 | Authorized biography records her habits and family longevity. | CLM-0004, CLM-0007 |
| February 1906 | Traveled to Washington, D.C., in failing health; went to bed on returning home. | CLM-0008 |
| March 13, 1906 | Died at home in Rochester of heart failure and pneumonia. | CLM-0009 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Susan B. Anthony was born on February 15, 1820, in Adams, Massachusetts, the second child of Daniel and Lucy Read Anthony. | confirmed | Susan B. Anthony supports Harper IH. The Life and Work of Susan B. Anthony, Volume 1. Indianapolis: Bowen-Merrill; 1898 supports |
| D | Anthony voted in the 1872 presidential election, was arrested at her Rochester home, and was convicted at Canandaigua, New York; she refused to pay the $100 fine. | confirmed | Susan B. Anthony supports |
| D | Her father, Daniel Anthony, who had not had a day's illness in forty years, was suddenly stricken in November 1862 with what was called acute neuralgia of the stomach and died two weeks later, on November 25, 1862, at 69. Contemporary description from the authorized biography; the modern cause cannot be determined. |
confirmed | Harper IH. The Life and Work of Susan B. Anthony, Volume 1. Indianapolis: Bowen-Merrill; 1898 supports Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 supports |
| D | Her 1898 biography describes a long-lived family: her mother died at eighty-six, her paternal grandfather lived past ninety-seven, and both maternal grandparents died in their eighty-fourth year. Causes of death are not recorded in the source. |
confirmed | Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 supports |
| D | In January 1891, after weeks of what seemed a persistent la grippe, Anthony collapsed at the Garrison home in Brookline, Massachusetts; pneumonia threatened and she kept to her room for a week. | confirmed | Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 supports |
| D | On July 26, 1895, near the end of an address at Lakeside, Ohio, Anthony stopped abruptly and fainted; from July 30 she spent a month in bed with what was called nervous prostration, described as her first serious illness in seventy-five years. The contemporary label does not establish a modern cause; no cardiac evaluation is recorded. |
confirmed | Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 supports |
| D | Her biographer described her daily habits in the late 1890s: a cold sponge bath each morning, simple food, tea and coffee in moderation, a rest after meals and an hour's rest each afternoon, and fresh air and exercise every day, walking from the station after a day on the train. Documents her baseline activity and habits; used for the synthetic social history. |
confirmed | Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 supports |
| D | In February 1906, although in failing health, Anthony traveled to Washington, D.C.; after returning to Rochester she went to bed, attended by Dr. Ricker and two nurses, and died about three weeks later. | confirmed | The nurses who attended Susan B. Anthony in her last illness supports |
| D | Anthony died at her home on Madison Street in Rochester, New York, at 12:40 a.m. on March 13, 1906, aged 86; the National Park Service records the cause as heart failure and pneumonia. The documented anchor for the synthetic heart failure episode. Record the death as a fact without graphic detail. |
confirmed | Susan B. Anthony supports Remember Susan B. Anthony on March 13 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Heart failure with preserved ejection fraction, NYHA class II to III at diagnosis; synthetic modern diagnosis linked to the documented 1785 heart failure | active | confirmed | both_with_link | CLM-0009 |
| S | Hypertensive heart disease with heart failure | active | confirmed | active | |
| S | Acute viral bronchitis after a head cold, resolved without antibiotics | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1905-03-16 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 1650 pg/mL (high) Reference <=125 pg/mL |
http://loinc.org · 33762-6 |
| S | 1905-03-16 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1905-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1905-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1905-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 64 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1905-03-16 | Glucose [Mass/volume] in Serum or Plasma | 96 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1905-03-16 | Magnesium [Mass/volume] in Serum or Plasma | 2 mg/dL Reference 1.6-2.6 mg/dL |
http://loinc.org · 19123-9 |
| S | 1905-03-16 | Hemoglobin [Mass/volume] in Blood | 12.4 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 1905-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 140 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 1905-03-16 | Iron saturation [Mass Fraction] in Serum or Plasma | 24% Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 1905-03-16 | Thyrotropin [Units/volume] in Serum or Plasma | 2.4 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1905-03-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 1905-03-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 96 mg/dL Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 1905-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1905-03-16 | Overall summary score [KCCQ-12] | 52 | http://loinc.org · 86924-8 |
| S | 1905-03-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1905-03-30 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1905-03-30 | Potassium [Moles/volume] in Serum or Plasma | 3.9 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1905-03-30 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1905-03-30 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 58 mL/min/1.73 m² (low) Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1905-03-30 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1905-03-30 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 mg/dL Reference 1.6-2.6 mg/dL |
http://loinc.org · 19123-9 |
| S | 1905-03-30 | Left ventricular Ejection fraction | 62% Reference 50-70% |
http://loinc.org · 10230-1 |
| S | 1905-03-30 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 42 mL/m² (high) Reference <=34 mL/m² |
http://loinc.org · 79984-1 |
| S | 1905-03-30 | Heart valve E velocity/Annulus E wave by US | 16 (high) Reference <=14 |
http://loinc.org · 59111-5 |
| S | 1905-06-29 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 720 pg/mL (high) Reference <=125 pg/mL |
http://loinc.org · 33762-6 |
| S | 1905-06-29 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1905-06-29 | Potassium [Moles/volume] in Serum or Plasma | 4.5 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1905-06-29 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1905-06-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 61 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1905-06-29 | Glucose [Mass/volume] in Serum or Plasma | 95 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1905-06-29 | Magnesium [Mass/volume] in Serum or Plasma | 2 mg/dL Reference 1.6-2.6 mg/dL |
http://loinc.org · 19123-9 |
| S | 1905-06-29 | Overall summary score [KCCQ-12] | 70 | http://loinc.org · 86924-8 |
| S | 1905-06-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1905-09-28 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1905-09-28 | Potassium [Moles/volume] in Serum or Plasma | 4.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1905-09-28 | Creatinine [Mass/volume] in Serum or Plasma | 0.9 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1905-09-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 63 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1905-09-28 | Glucose [Mass/volume] in Serum or Plasma | 93 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1905-09-28 | Overall summary score [KCCQ-12] | 76 | http://loinc.org · 86924-8 |
| S | 1905-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1905-10-19 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
| S | 1905-10-19 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1905-03-16 | Body height | 165 cm | 8302-2 | S |
| 1905-03-16 | Body weight | 58.5 kg | 29463-7 | S |
| 1905-03-16 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 1905-03-16 | Systolic blood pressure | 158 mm[Hg] | 8480-6 | S |
| 1905-03-16 | Diastolic blood pressure | 86 mm[Hg] | 8462-4 | S |
| 1905-03-16 | Heart rate | 84 /min | 8867-4 | S |
| 1905-03-16 | Respiratory rate | 20 /min | 9279-1 | S |
| 1905-03-16 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1905-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 1905-03-30 | Body height | 165 cm | 8302-2 | S |
| 1905-03-30 | Body weight | 56.8 kg | 29463-7 | S |
| 1905-03-30 | Body mass index (BMI) [Ratio] | 20.9 kg/m2 | 39156-5 | S |
| 1905-03-30 | Systolic blood pressure | 146 mm[Hg] | 8480-6 | S |
| 1905-03-30 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 1905-03-30 | Heart rate | 78 /min | 8867-4 | S |
| 1905-03-30 | Respiratory rate | 18 /min | 9279-1 | S |
| 1905-03-30 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1905-03-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 1905-06-29 | Body height | 165 cm | 8302-2 | S |
| 1905-06-29 | Body weight | 56.2 kg | 29463-7 | S |
| 1905-06-29 | Body mass index (BMI) [Ratio] | 20.6 kg/m2 | 39156-5 | S |
| 1905-06-29 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 1905-06-29 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1905-06-29 | Heart rate | 72 /min | 8867-4 | S |
| 1905-06-29 | Respiratory rate | 16 /min | 9279-1 | S |
| 1905-06-29 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1905-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1905-09-28 | Body height | 165 cm | 8302-2 | S |
| 1905-09-28 | Body weight | 56 kg | 29463-7 | S |
| 1905-09-28 | Body mass index (BMI) [Ratio] | 20.6 kg/m2 | 39156-5 | S |
| 1905-09-28 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1905-09-28 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1905-09-28 | Heart rate | 70 /min | 8867-4 | S |
| 1905-09-28 | Respiratory rate | 16 /min | 9279-1 | S |
| 1905-09-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1905-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1905-08-17 | Body height | 165 cm | 8302-2 | S |
| 1905-08-17 | Body weight | 56.3 kg | 29463-7 | S |
| 1905-08-17 | Body mass index (BMI) [Ratio] | 20.7 kg/m2 | 39156-5 | S |
| 1905-08-17 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1905-08-17 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1905-08-17 | Heart rate | 88 /min | 8867-4 | S |
| 1905-08-17 | Respiratory rate | 18 /min | 9279-1 | S |
| 1905-08-17 | Body temperature | 37.4 Cel | 8310-5 | S |
| 1905-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 1905-10-19 | Body height | 165 cm | 8302-2 | S |
| 1905-10-19 | Body weight | 56.1 kg | 29463-7 | S |
| 1905-10-19 | Body mass index (BMI) [Ratio] | 20.6 kg/m2 | 39156-5 | S |
| 1905-10-19 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1905-10-19 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1905-10-19 | Heart rate | 68 /min | 8867-4 | S |
| 1905-10-19 | Respiratory rate | 16 /min | 9279-1 | S |
| 1905-10-19 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1905-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: national advocacy leader who still lectures and travels by train and air most months
- S Never smoker; no alcohol; tea and coffee in moderation; simple diet with fruit at every meal
- S Lives in her own house with her sister; walks daily and rests after meals
- S Supports: sister, nieces, and a close circle of younger colleagues
Functional status
- S Independent in all activities of daily living; breathless after one flight of stairs or a long station platform at intake; NYHA class II to III
- S Walking two miles a day again and back on the lecture circuit by the six-month review
Mental status
- S Alert, oriented, quick, and forthright; impatient with being ill
- S Mood euthymic; PHQ-2 negative
Allergies and medications
Allergies
- S No known allergy
Medications
- S Furosemide 20 mg oral tablet, one tablet by mouth daily
- S Furosemide 20 mg oral tablet, one tablet by mouth as needed for a weight gain of more than 1 kg in a day or 2 kg in a week
- S Empagliflozin 10 mg oral tablet, one tablet by mouth daily
- S Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) by mouth daily
Procedures and immunizations
Procedures
- S 12-lead electrocardiogram: sinus rhythm, left ventricular hypertrophy by voltage, no atrial fibrillation
- S Transthoracic echocardiography: ejection fraction 62 percent, concentric remodeling with septal thickness 11 mm, enlarged left atrium, raised filling pressures, no significant valve disease
Immunizations
- S 1904-10-06: High-dose influenza vaccine, 1904-1905 season
- S 1905-03-30: Pneumococcal conjugate vaccine PCV20
- S 1905-03-30: Respiratory syncytial virus vaccine, single dose
- S 1901-11-14: Recombinant zoster vaccine, two-dose series completed
- S 1899-05-11: Tdap vaccine
- S 1905-10-19: High-dose influenza vaccine, 1905-1906 season
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D January 1891: Prolonged la grippe with collapse; pneumonia threatened and she kept to her room for a week (CLM-0005)
- D July 26, 1895: Fainted while speaking at Lakeside, Ohio, followed by a month in bed with what was called nervous prostration; no cardiac evaluation recorded (CLM-0006)
Family history
- D father: Died November 25, 1862, at 69, after a sudden two-week illness then called acute neuralgia of the stomach
- D mother: Died at 86; cause not recorded in the cited source
- D paternal grandfather: Lived past 97; cause of death not recorded in the cited source
- D maternal grandmother: Died in her eighty-fourth year; cause not recorded in the cited source
- D maternal grandfather: Died in his eighty-fourth year; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Reach euvolemia with no ankle edema and a stable dry weight within three months | 1905-06-29 | completed | Dry weight 56 kg; furosemide changed to as-needed use |
| Improve the KCCQ-12 overall summary score by at least 15 points by the three-month review | 1905-06-29 | completed | KCCQ-12 rose from 52 to 70 |
| Lower blood pressure below 130/80 by the six-month review without orthostatic symptoms | 1905-09-28 | completed | Blood pressure 126/72; no dizziness on standing |
| Resume a full speaking and travel schedule by the six-month review | 1905-09-28 | completed | Back to lecturing twice a month with a travel weight plan |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Treat congestion with furosemide and start empagliflozin for HFpEF; move to as-needed furosemide guided by daily weights once euvolemic | completed | GL-HF-2022, GL-HFPEF-2023 |
| Add low-dose spironolactone for HFpEF with blood pressure above target once potassium and kidney function are stable | completed | GL-HF-2022, GL-HFPEF-2023 |
| Cardiology referral to confirm the diagnosis, review the echocardiogram, and look for specific causes such as amyloidosis or valve disease | completed | GL-HF-2022, GL-HFPEF-2023 |
| Check a basic metabolic panel and magnesium one to two weeks after starting or changing diuretic, SGLT2 inhibitor, or mineralocorticoid antagonist therapy, then every three to six months; KCCQ-12 every three to six months | completed | GL-CMID-2026, GL-HF-2022 |
| Daily weights, sodium moderation, a written travel plan for weight gain, and continued daily walking; refer to cardiac rehabilitation if exercise tolerance plateaus | completed | GL-HF-2022, GL-CMID-2026 |
| Pneumococcal and RSV vaccination and a yearly high-dose influenza vaccine to lower the risk of respiratory infection in heart failure | completed | GL-HF-2022, GL-CMID-2026 |
Planned encounters
- 1905-03-16 — Primary care visit for breathlessness on exertion and ankle swelling (ENC-001)
- 1905-03-30 — Two-week heart failure medication safety check, echocardiogram, and cardiology consultation (ENC-002)
- 1905-06-29 — Three-month heart failure and blood pressure review (ENC-003)
- 1905-08-17 — Same-day sick visit for a head cold and cough (ENC-005, unscheduled)
- 1905-09-28 — Six-month heart failure review (ENC-004)
- 1905-10-19 — Subsequent annual wellness visit (ENC-006)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Care-plan review)
- Progress note 06 — Annual Wellness Visit, Subsequent
- Cardiology referral
- Cardiology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Care-plan review) (XML)
- Progress note 06 — Annual Wellness Visit, Subsequent (XML)
- Cardiology referral (XML)
- Cardiology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Susan B. Anthony | U.S. National Park Service | government |
| SRC-0002 | Harper IH. The Life and Work of Susan B. Anthony, Volume 1. Indianapolis: Bowen-Merrill; 1898 | Project Gutenberg (eBook 15220) | biography |
| SRC-0003 | Harper IH. The Life and Work of Susan B. Anthony, Volume 2. Indianapolis: Bowen-Merrill; 1898 | Project Gutenberg (eBook 31125) | biography |
| SRC-0004 | Remember Susan B. Anthony on March 13 | National Susan B. Anthony Museum & House | other |
| SRC-0005 | The nurses who attended Susan B. Anthony in her last illness | National Susan B. Anthony Museum & House | other |
| SRC-0006 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check HFpEF therapy choices and potassium monitoring in an 85-year-old. |
| provenance review | not_started | NPS page, the 1898 Harper biography (Project Gutenberg), and two museum pages logged; reports of valvular heart disease were not verified and are not used. |
| safe messaging review | not_started | No behavioral-health content; death recorded without graphic detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.